Approach to radiation therapy in the Jehovah's Witness patient: An overview

James M. Jurica; Jay A. Messer; Bin S. Teh; E. Brian Butler; Andrew M. Farach

doi:10.1016/j.rpor.2020.08.014

Approach to radiation therapy in the Jehovah's Witness patient: An overview

James M. Jurica, Jay A. Messer, Bin S. Teh, E. Brian Butler, Andrew M. Farach

Research output: Contribution to journal › Review article › peer-review

Abstract

Jehovah's Witnesses are well-known in the medical community for their inability to accept blood products. Novel methods of treatment are often needed to avoid anemia and hematologic toxicity as inability to receive blood products may increase the risk of treatment related complications. We provide an overview of radiation treatment for Jehovah's Witness patients with an emphasis on bone marrow sparing strategies with intensity modulated radiation therapy (IMRT) to minimize hematologic toxicity.

Original language	English (US)
Pages (from-to)	856-859
Number of pages	4
Journal	Reports of Practical Oncology and Radiotherapy
Volume	25
Issue number	6
DOIs	https://doi.org/10.1016/j.rpor.2020.08.014
State	Published - Nov 1 2020

Keywords

Anemia
BMS-IMRT
Bone marrow sparing
Hematologic toxicity
Jehovah witness
Radiation oncology

ASJC Scopus subject areas

Oncology
Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.rpor.2020.08.014

Cite this

@article{36fa4839a13f4c3fbe68295db5a91b3a,

title = "Approach to radiation therapy in the Jehovah's Witness patient: An overview",

abstract = "Jehovah's Witnesses are well-known in the medical community for their inability to accept blood products. Novel methods of treatment are often needed to avoid anemia and hematologic toxicity as inability to receive blood products may increase the risk of treatment related complications. We provide an overview of radiation treatment for Jehovah's Witness patients with an emphasis on bone marrow sparing strategies with intensity modulated radiation therapy (IMRT) to minimize hematologic toxicity.",

keywords = "Anemia, BMS-IMRT, Bone marrow sparing, Hematologic toxicity, Jehovah witness, Radiation oncology",

author = "Jurica, {James M.} and Messer, {Jay A.} and Teh, {Bin S.} and Butler, {E. Brian} and Farach, {Andrew M.}",

year = "2020",

month = nov,

day = "1",

doi = "10.1016/j.rpor.2020.08.014",

language = "English (US)",

volume = "25",

pages = "856--859",

journal = "Reports of Practical Oncology and Radiotherapy",

issn = "1507-1367",

publisher = "Elsevier Sp. z o.o.",

number = "6",

}

TY - JOUR

T1 - Approach to radiation therapy in the Jehovah's Witness patient

T2 - An overview

AU - Jurica, James M.

AU - Messer, Jay A.

AU - Teh, Bin S.

AU - Butler, E. Brian

AU - Farach, Andrew M.

PY - 2020/11/1

Y1 - 2020/11/1

N2 - Jehovah's Witnesses are well-known in the medical community for their inability to accept blood products. Novel methods of treatment are often needed to avoid anemia and hematologic toxicity as inability to receive blood products may increase the risk of treatment related complications. We provide an overview of radiation treatment for Jehovah's Witness patients with an emphasis on bone marrow sparing strategies with intensity modulated radiation therapy (IMRT) to minimize hematologic toxicity.

AB - Jehovah's Witnesses are well-known in the medical community for their inability to accept blood products. Novel methods of treatment are often needed to avoid anemia and hematologic toxicity as inability to receive blood products may increase the risk of treatment related complications. We provide an overview of radiation treatment for Jehovah's Witness patients with an emphasis on bone marrow sparing strategies with intensity modulated radiation therapy (IMRT) to minimize hematologic toxicity.

KW - Anemia

KW - BMS-IMRT

KW - Bone marrow sparing

KW - Hematologic toxicity

KW - Jehovah witness

KW - Radiation oncology

UR - http://www.scopus.com/inward/record.url?scp=85090714333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85090714333&partnerID=8YFLogxK

U2 - 10.1016/j.rpor.2020.08.014

DO - 10.1016/j.rpor.2020.08.014

M3 - Review article

C2 - 32982590

AN - SCOPUS:85090714333

SN - 1507-1367

VL - 25

SP - 856

EP - 859

JO - Reports of Practical Oncology and Radiotherapy

JF - Reports of Practical Oncology and Radiotherapy

IS - 6

ER -

Approach to radiation therapy in the Jehovah's Witness patient: An overview

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this